<DOC>
	<DOCNO>NCT02036164</DOCNO>
	<brief_summary>Data survival benefit adjuvant chemotherapy ( ACT ) concurrent chemoradiation ( CCRT ) locally advanced cervical cancer ( LACC ) still limited inconsistent . We investigate ACT survival benefit CCRT alone .</brief_summary>
	<brief_title>Adjuvant Chemotherapy Locally Advanced Cervical Cancer</brief_title>
	<detailed_description>Concurrent chemoradiation ( CCRT ) standard treatment cervical cancer FIGO stage IIB-IVA call locally advanced cervical cancer ( LACC ) . However , failure rate treatment still high 30 % 40 % . This multi-center randomized control trial evaluate whether adjuvant chemotherapy ( ACT ) CCRT improve treatment outcome compare CCRT alone .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Age 1870 year Cervical cancer FIGO stage IIBIVA Histopathology squamous cell carcinoma , adenocarcinoma , adenosquamous cell carcinoma ECOG performance status 02 No history cancer except basal cell carcinoma Adequate bone marrow function ( WBC &gt; = 3,000/mm3 , granulocyte &gt; = 1,500/mm3 , platelet count &gt; = 100,000/mm3 ) Bilirubin &lt; 1.5 fold , SGOT/ SGPT &lt; 1.5 fold normal limit , creatinine clearance &gt; = 40 mg/dl Consent participate Paraaortic lymph node enlargement &gt; 1 cm suspicious cancer metastasis CT MRI Adnexal mass physical examination image study Chronic illnesses e.g . renal failure/ impairment , peripheral central neuropathy , uncontrolled diabetes mellitus , HIV infection . Pregnancy lactation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Locally advanced cervical cancer</keyword>
	<keyword>Concurrent chemoradiation</keyword>
	<keyword>Adjuvant chemotherapy</keyword>
</DOC>